Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,807 | 3,125 | 2,750 | 4,092 | 5,822 |
| TOTAL | $3,807 | $3,125 | $2,750 | $4,092 | $5,822 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 1 | 2 | 3 |
| TOTAL | $N/A | $N/A | $1 | $2 | $3 |
| Total Assets | $3,807 | $3,125 | $2,751 | $4,094 | $5,825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,109 | 1,297 | 1,048 | 1,178 | 775 |
| Other current liabilities | 207 | 83 | 84 | 76 | 68 |
| TOTAL | $1,622 | $1,686 | $1,439 | $1,560 | $842 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 306 | 306 | 306 | 306 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,622 | $1,686 | $1,439 | $1,560 | $842 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,855 | 13,630 | 13,368 | 13,274 | 13,145 |
| Common Shares | 14 | 14 | 13 | 13 | 13 |
| Retained earnings | -77,589 | -73,437 | -69,412 | -66,153 | -58,113 |
| TOTAL | $2,185 | $1,440 | $1,312 | $2,534 | $4,983 |
| Total Liabilities And Equity | $3,807 | $3,125 | $2,751 | $4,094 | $5,825 |